Ligand Reports First Quarter 2026 Financial Results
Go back to Ligand Reports First Quarter 2026 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 294.99 -8.54 (2.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $303.53 | 52 Week High | $139.79 | |||
| Open | $299.55 | 52 Week Low | $82.07 | |||
| Day High | $307.11 | P/E | 686.02 | |||
| Day Low | $292.28 | EPS | $0.43 | |||
| Volume | 245,284 | |||||



